NCT00027534View on ClinicalTrials.gov

Vaccine Therapy in Treating Patients With Advanced or Metastatic Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

January 31, 2002

Primary Completion Date

October 31, 2007

Study Completion Date

October 31, 2007

Conditions
Breast CancerColorectal CancerGallbladder CancerGastric CancerHead and Neck CancerLiver CancerOvarian CancerPancreatic CancerTesticular Germ Cell Tumor
Interventions
BIOLOGICAL

TRICOM-CEA(6D)

dendritic cells loaded with TRICOM-CEA(6D)

Trial Locations (1)

27705

Duke Comprehensive Cancer Center, Durham

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Michael Morse, MD

OTHER

NCT00027534 - Vaccine Therapy in Treating Patients With Advanced or Metastatic Cancer | Biotech Hunter | Biotech Hunter